Drug Testing Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Sample (Urine Samples, Oral Fluid Samples), By Drug (Alcohol, Cannabis/Marijuana, Cocaine), By End-use, By Region, And Segment Forecasts, 2024 - 2030
Drug Testing Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Sample (Urine Samples, Oral Fluid Samples), By Drug (Alcohol, Cannabis/Marijuana, Cocaine), By End-use, By Region, And Segment Forecasts, 2024 - 2030
Drug Testing Market Growth & Trends
The global drug testing market size is expected to reach USD 8.45 billion by 2030, expanding at a CAGR of 4.8% from 2024 to 2030, according to a new report by Grand View Research, Inc.. The introduction of innovative tests, stringent regulation mandating drug testing, and growing substance abuse & addiction are some of the factors anticipated to foster market growth during the forecast period.
Drug abuse and addiction is a global problem, affecting millions of people. As per the World Drug Report published by UNODC, in 2019, around 35.0 million people were suffering from drug use disorders globally. Such a high rate of drug abuse and substance use disorders has created a major demand for innovative tests to prevent, treat, and manage such cases. Several key players operating in this space are introducing innovative and efficient products to meet this growing demand.
For instance, in June 2019, Quidel Corporation received the U.S. FDA’s 510(k) clearance to market its fluorescence immunoassay—Quidel Triage TOX Drug Screen, 94600. This is intended for detecting the presence of metabolites or drugs in urine. Moreover, in June 2020, Cordant Health Solutions offered video-observed oral fluid drug testing to help courts & government agencies to monitor participants during the COVID-19 pandemic. This aided in combating several challenges faced by people with substance abuse disorders during the pandemic.
Continuous government initiatives and implementation of strict substance abuse testing regulations to ensure safety have derived the demand for its testing products. In July 2020, the New Zealand government introduced a new bill that provides police the power to conduct random roadside drug testing of drivers to reduce impaired driving in the country. The new bill allows usage of oral fluid tests to check drivers for substances such as cocaine, ecstasy, cannabis, opiates, methamphetamine, and benzodiazepines. Also, in February 2020, the Directorate General of Civil Aviation in India introduced extensive tests for pilots and flight crew members for psychoactive substances such as opioids & cannabis to ensure safe air travel.
Drug Testing Market Report Highlights
By product type, the consumables segment dominated the market in 2023, owing to its repetitive use to conduct substance abuse screening
Based on sample type, the urine samples segment accounted for the largest revenue share in 2023, as it is the most common method of sample collection
Increased unemployment and economic crisis due to the Covid-19 pandemic has made people more susceptible to substance abuse, thus created lucrative opportunities in the market
The legalization of marijuana for medicinal as well as recreational use in several countries is anticipated to change the current scenario and may create demand for innovative testing solutions
Stringent privacy rights in some countries are likely to limit substance abuse testing at workplaces, impeding market growth
In Asia Pacific, the market is expected to witness lucrative growth over the forecast period as a result of the growing demand for substance abuse testing from emerging economies, such as China and India
Please note The report will be delivered in 2-3 business days upon order notification.
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Sample
1.2.3. Drug
1.2.4. End Use
1.2.5. Regional scope
1.2.6. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Sample outlook
2.2.3. Drug outlook
2.2.4. End Use outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Drug Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. High prevalence of substance abuse
3.2.1.2. Stringent laws mandating alcohol and drug testing
3.2.1.3. Increasing government initiatives to monitor substance abuse
3.2.2. Market restraint analysis
3.2.2.1. Drug testing is considered a violation of privacy rights in some countries
3.3. Drug Testing Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Drug Testing Market: Product Estimates & Trend Analysis
4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Drug Testing Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Consumables
4.4.1.1. Consumables Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Instruments
4.4.2.1. Instruments Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Rapid Testing Devices
4.4.3.1. Rapid Testing Devices Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Services
4.4.4.1. Services Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Others
4.4.5.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Drug Testing Market: Sample Estimates & Trend Analysis
5.1. Sample Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Drug Testing Market by Sample Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Urine Samples
5.4.1.1. Urine Samples Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Oral Fluid Samples
5.4.2.1. Oral Fluid Samples Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Hair Samples
5.4.3.1. Hair Samples Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Other Samples
5.4.4.1. Other Samples Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Drug Testing Market: Drug Type Estimates & Trend Analysis
6.1. Drug Type Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Drug Testing Market by Drug type Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Alcohol
6.4.1.1. Alcohol Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Cannabis/Marijuana
6.4.2.1. Cannabis/Marijuana Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Cocaine
6.4.3.1. Cocaine Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4. Opioids
6.4.4.1. Opioids market estimates and forecasts 2018 to 2030 (USD Million)
6.4.5. Amphetamine & Methamphetamine
6.4.5.1. Amphetamine & Methamphetamine Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.6. LSD
6.4.6.1. LSD Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.7. Others
6.4.7.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Drug Testing Market: End Use Estimates & Trend Analysis
7.1. End Use Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. Global Drug Testing Market by End Use Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.4.1. Drug Testing Laboratories
7.4.1.1. Drug Testing Laboratories Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Workplaces
7.4.2.1. Workplaces Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. Hospitals
7.4.3.1. Hospitals Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Others
7.4.4.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Drug Testing Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.5. North America
8.5.1. North America: SWOT Analysis
8.5.2. U.S.
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework
8.5.2.3. Competitive scenario
8.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. Canada
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework
8.5.3.3. Competitive scenario
8.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Europe
8.6.1. Europe: SWOT Analysis
8.6.2. UK
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework
8.6.2.3. Competitive scenario
8.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. Germany
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework
8.6.3.3. Competitive scenario
8.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. France
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework
8.6.4.3. Competitive scenario
8.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. Italy
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework
8.6.5.3. Competitive scenario
8.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. Spain
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework
8.6.6.3. Competitive scenario
8.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.6.7. Norway
8.6.7.1. Key country dynamics
8.6.7.2. Regulatory framework
8.6.7.3. Competitive scenario
8.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.6.8. Sweden
8.6.8.1. Key country dynamics
8.6.8.2. Regulatory framework
8.6.8.3. Competitive scenario
8.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.6.9. Denmark
8.6.9.1. Key country dynamics
8.6.9.2. Regulatory framework
8.6.9.3. Competitive scenario
8.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Asia Pacific
8.7.1. Asia Pacific: SWOT Analysis
8.7.2. Japan
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework
8.7.2.3. Competitive scenario
8.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.7.3. China
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework
8.7.3.3. Competitive scenario
8.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
8.7.4. India
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework
8.7.4.3. Competitive scenario
8.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
8.7.5. Australia
8.7.5.1. Key country dynamics
8.7.5.2. Regulatory framework
8.7.5.3. Competitive scenario
8.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.7.6. South Korea
8.7.6.1. Key country dynamics
8.7.6.2. Regulatory framework
8.7.6.3. Competitive scenario
8.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.7.7. Thailand
8.7.7.1. Key country dynamics
8.7.7.2. Regulatory framework
8.7.7.3. Competitive scenario
8.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.8. Latin America
8.8.1. Latin America: SWOT Analysis
8.8.2. Brazil
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework
8.8.2.3. Competitive scenario
8.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.8.3. Mexico
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework
8.8.3.3. Competitive scenario
8.8.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.8.4. Argentina
8.8.4.1. Key country dynamics
8.8.4.2. Regulatory framework
8.8.4.3. Competitive scenario
8.8.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.9. MEA
8.9.1. MEA: SWOT Analysis
8.9.2. South Africa
8.9.2.1. Key country dynamics
8.9.2.2. Regulatory framework
8.9.2.3. Competitive scenario
8.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.9.3. Saudi Arabia
8.9.3.1. Key country dynamics
8.9.3.2. Regulatory framework
8.9.3.3. Competitive scenario
8.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.9.4. UAE
8.9.4.1. Key country dynamics
8.9.4.2. Regulatory framework
8.9.4.3. Competitive scenario
8.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.9.5. Kuwait
8.9.5.1. Key country dynamics
8.9.5.2. Regulatory framework
8.9.5.3. Competitive scenario
8.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2023
9.3.4. Quest Diagnostics Incorporated
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Services benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Abbott
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Services benchmarking
9.3.5.4. Strategic initiatives
9.3.6. F. Hoffmann-La Roche Ltd.
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Services benchmarking
9.3.6.4. Strategic initiatives
9.3.7. Quidel Corporation
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Services benchmarking
9.3.7.4. Strategic initiatives
9.3.8. Thermo Fisher Scientific, Inc.
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Services benchmarking
9.3.8.4. Strategic initiatives
9.3.9. Siemens Healthcare GmbH
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Services benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Bio-Rad Laboratories, Inc.
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Services benchmarking
9.3.10.4. Strategic initiatives
9.3.11. Agilent Technologies, Inc.
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Services benchmarking
9.3.11.4. Strategic initiatives
9.3.12. Laboratory Corporation of America Holdings